Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-58.43	18.12	43.58
Graham Fair Price	76.11	11155.24	6334.41
PEG	4.27	0.02	-0.02
Price/Book	-7.35	0.60	0.65
Price/Cash Flow	-50.74	13.50	-27.41
Prices/Earnings	-67.99	4.78	14.94
Price/Sales	-26.30	1.03	1.39
Price/FCF	-50.74	13.50	-27.41
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-0.07	0.22	0.22
Operating Margin	214.57	0.07	0.02
ROA	188.89	0.02	< 0.005
ROE	0.01	0.03	189.49
ROIC	< 0.005	0.02	293.61
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	< 0.005	-899.38
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.85	3.09	265.23
EPS QOQ	6.50	2.00	-69.31
FCF QOQ	-1.40	2.95	110.20
Revenue QOQ	-0.13	0.30	131.54
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	85.83	63.81	-25.66
Days Sales Outstanding (DSO)	102.21	90.03	-11.92
Inventory Turnover	1.05	1.41	34.52
Debt/Capitalization	0.33	0.32	-3.01
Quick Ratio	0.88	0.90	1.63
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	12851.98	13329.26	3.71
Cash	1702.06	1815.36	6.66
Capex	-144.47	70.05	-51.51
Free Cash Flow	-302.41	588.74	94.68
Revenue	5951.28	7743.33	30.11
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.35	1.29	-4.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.11	6.74	-58.18
Naive Interpretation	Member

06 - Financial Health · Weak

Rating